CIK 0000908259
- Non-accelerated filer
- Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133679168
- Phone
- +1 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at an average $3.96 ($19,790)
- 4 Open-market buy Director bought 50,000 shares at $3.95 ($197,500)
- 4 Open-market buy Director bought 20,000 shares at an average $3.93 ($78,508)
- 4 Open-market buy Director bought 50,000 shares at $3.85 ($192,300)
- 4/A Grant or award Director acquired 40,000 shares (grant or award)
- 4/A Grant or award Director acquired 40,000 shares (grant or award)
- 4/A Grant or award Director acquired 40,000 shares (grant or award)
- 4/A Grant or award Director acquired 40,000 shares (grant or award)
- 4/A Grant or award Chief Operating Officer acquired 40,000 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
- 4/A Grant or award Chief Scientific Officer acquired 80,000 shares (grant or award)
- 4/A Grant or award President and CEO acquired 80,000 shares (grant or award)
- 4/A Grant or award Director acquired 80,000 shares (grant or award)
- 4 Open-market buy Director bought 100,000 shares at $5.09 ($509,000)
- 4 Grant or award Director acquired 40,000 shares (grant or award)
Page 12 of 17 · 325 filings